Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.96 Billion USD | 17.14% |
| 2022 | 2.53 Billion USD | 4.67% |
| 2021 | 2.41 Billion USD | 21.66% |
| 2020 | 1.98 Billion USD | -4.11% |
| 2019 | 2.07 Billion USD | 9.34% |
| 2018 | 1.89 Billion USD | 7.34% |
| 2017 | 1.76 Billion USD | 9.59% |
| 2016 | 1.61 Billion USD | -0.77% |
| 2015 | 1.62 Billion USD | -10.23% |
| 2014 | 1.8 Billion USD | -1.66% |
| 2013 | 1.83 Billion USD | 2.68% |
| 2012 | 1.79 Billion USD | 8.46% |
| 2011 | 1.65 Billion USD | 26.58% |
| 2010 | 1.3 Billion USD | 17.08% |
| 2009 | 1.11 Billion USD | 0.67% |
| 2008 | 1.1 Billion USD | 102.18% |
| 2007 | 547.57 Million USD | 25.64% |
| 2006 | 435.83 Million USD | 46.46% |
| 2005 | 297.56 Million USD | 4.62% |
| 2004 | 284.41 Million USD | 9.11% |
| 2003 | 260.67 Million USD | 124.01% |
| 2002 | 116.36 Million USD | 25.54% |
| 2001 | 92.69 Million USD | 21.0% |
| 2000 | 76.6 Million USD | 18.41% |
| 1999 | 64.69 Million USD | 53.27% |
| 1998 | 42.2 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 721.7 Million USD | -15.54% |
| 2024 Q3 | 864.4 Million USD | 7.96% |
| 2024 Q2 | 800.7 Million USD | 10.95% |
| 2023 Q2 | 681.9 Million USD | -0.5% |
| 2023 FY | 2.96 Billion USD | 17.14% |
| 2023 Q1 | 685.3 Million USD | -3.26% |
| 2023 Q4 | 854.5 Million USD | 15.04% |
| 2023 Q3 | 742.8 Million USD | 8.93% |
| 2022 FY | 2.53 Billion USD | 4.67% |
| 2022 Q1 | 595 Million USD | -12.95% |
| 2022 Q2 | 588.4 Million USD | -1.11% |
| 2022 Q3 | 638.9 Million USD | 8.58% |
| 2022 Q4 | 708.4 Million USD | 10.88% |
| 2021 FY | 2.41 Billion USD | 21.66% |
| 2021 Q3 | 608.9 Million USD | 6.67% |
| 2021 Q2 | 570.8 Million USD | 2.9% |
| 2021 Q1 | 554.7 Million USD | -11.6% |
| 2021 Q4 | 683.5 Million USD | 12.25% |
| 2020 Q3 | 511.4 Million USD | 20.44% |
| 2020 FY | 1.98 Billion USD | -4.11% |
| 2020 Q4 | 627.5 Million USD | 22.7% |
| 2020 Q2 | 424.6 Million USD | 0.14% |
| 2020 Q1 | 424 Million USD | -29.32% |
| 2019 FY | 2.07 Billion USD | 9.34% |
| 2019 Q4 | 599.9 Million USD | 15.12% |
| 2019 Q1 | 461.4 Million USD | -16.65% |
| 2019 Q2 | 490.2 Million USD | 6.24% |
| 2019 Q3 | 521.1 Million USD | 6.3% |
| 2018 Q1 | 431.7 Million USD | -18.62% |
| 2018 Q2 | 443.7 Million USD | 2.78% |
| 2018 FY | 1.89 Billion USD | 7.34% |
| 2018 Q4 | 553.6 Million USD | 18.65% |
| 2018 Q3 | 466.6 Million USD | 5.16% |
| 2017 Q1 | 384.9 Million USD | -18.16% |
| 2017 FY | 1.76 Billion USD | 9.59% |
| 2017 Q3 | 435.6 Million USD | 4.99% |
| 2017 Q4 | 530.5 Million USD | 21.79% |
| 2017 Q2 | 414.9 Million USD | 7.79% |
| 2016 FY | 1.61 Billion USD | -0.77% |
| 2016 Q4 | 470.3 Million USD | 19.4% |
| 2016 Q3 | 393.9 Million USD | 5.97% |
| 2016 Q2 | 371.7 Million USD | -0.99% |
| 2016 Q1 | 375.4 Million USD | -21.5% |
| 2015 Q3 | 396.1 Million USD | 0.03% |
| 2015 FY | 1.62 Billion USD | -10.23% |
| 2015 Q4 | 478.2 Million USD | 20.73% |
| 2015 Q1 | 353.5 Million USD | -30.41% |
| 2015 Q2 | 396 Million USD | 12.02% |
| 2014 Q1 | 423.7 Million USD | -23.26% |
| 2014 Q3 | 419.8 Million USD | -8.22% |
| 2014 Q4 | 508 Million USD | 21.01% |
| 2014 FY | 1.8 Billion USD | -1.66% |
| 2014 Q2 | 457.4 Million USD | 7.95% |
| 2013 FY | 1.83 Billion USD | 2.68% |
| 2013 Q4 | 552.1 Million USD | 25.76% |
| 2013 Q3 | 439 Million USD | -3.5% |
| 2013 Q2 | 454.9 Million USD | 15.63% |
| 2013 Q1 | 393.4 Million USD | -23.95% |
| 2012 FY | 1.79 Billion USD | 8.46% |
| 2012 Q1 | 405.6 Million USD | -14.63% |
| 2012 Q2 | 420.7 Million USD | 3.72% |
| 2012 Q3 | 447.8 Million USD | 6.44% |
| 2012 Q4 | 517.3 Million USD | 15.52% |
| 2011 FY | 1.65 Billion USD | 26.58% |
| 2011 Q1 | 357 Million USD | -14.2% |
| 2011 Q3 | 418.4 Million USD | 4.29% |
| 2011 Q2 | 401.2 Million USD | 12.38% |
| 2011 Q4 | 475.1 Million USD | 13.55% |
| 2010 Q3 | 310.2 Million USD | 3.09% |
| 2010 Q2 | 300.9 Million USD | 8.35% |
| 2010 FY | 1.3 Billion USD | 17.08% |
| 2010 Q4 | 416.1 Million USD | 34.14% |
| 2010 Q1 | 277.7 Million USD | -24.21% |
| 2009 Q1 | 230.5 Million USD | -26.86% |
| 2009 FY | 1.11 Billion USD | 0.67% |
| 2009 Q4 | 366.4 Million USD | 38.21% |
| 2009 Q3 | 265.1 Million USD | 4.99% |
| 2009 Q2 | 252.5 Million USD | 9.54% |
| 2008 FY | 1.1 Billion USD | 102.18% |
| 2008 Q4 | 315.13 Million USD | 30.19% |
| 2008 Q3 | 242.06 Million USD | -22.31% |
| 2008 Q2 | 311.56 Million USD | 30.67% |
| 2008 Q1 | 238.43 Million USD | 29.77% |
| 2007 Q1 | 110.5 Million USD | -18.52% |
| 2007 Q2 | 121.68 Million USD | 10.11% |
| 2007 FY | 547.57 Million USD | 25.64% |
| 2007 Q3 | 131.64 Million USD | 8.19% |
| 2007 Q4 | 183.74 Million USD | 39.58% |
| 2006 Q2 | 77.84 Million USD | 4.61% |
| 2006 Q1 | 74.41 Million USD | -7.63% |
| 2006 FY | 435.83 Million USD | 46.46% |
| 2006 Q3 | 104.87 Million USD | 34.73% |
| 2006 Q4 | 135.62 Million USD | 29.33% |
| 2005 FY | 297.56 Million USD | 4.62% |
| 2005 Q2 | 71.36 Million USD | -4.73% |
| 2005 Q1 | 74.91 Million USD | -12.52% |
| 2005 Q3 | 70.73 Million USD | -0.88% |
| 2005 Q4 | 80.55 Million USD | 13.88% |
| 2004 Q1 | 68.15 Million USD | -7.47% |
| 2004 Q3 | 66.47 Million USD | 3.63% |
| 2004 Q4 | 85.63 Million USD | 28.82% |
| 2004 Q2 | 64.14 Million USD | -5.88% |
| 2004 FY | 284.41 Million USD | 9.11% |
| 2003 Q2 | 34.42 Million USD | 0.94% |
| 2003 Q1 | 34.1 Million USD | 3.53% |
| 2003 Q4 | 73.65 Million USD | 16.81% |
| 2003 Q3 | 63.05 Million USD | 83.18% |
| 2003 FY | 260.67 Million USD | 124.01% |
| 2002 Q1 | 25.78 Million USD | 4.46% |
| 2002 FY | 116.36 Million USD | 25.54% |
| 2002 Q4 | 32.94 Million USD | 10.94% |
| 2002 Q3 | 29.69 Million USD | 6.25% |
| 2002 Q2 | 27.94 Million USD | 8.4% |
| 2001 Q1 | 21.9 Million USD | 0.54% |
| 2001 FY | 92.69 Million USD | 21.0% |
| 2001 Q4 | 24.68 Million USD | 3.76% |
| 2001 Q3 | 23.78 Million USD | 6.63% |
| 2001 Q2 | 22.31 Million USD | 1.83% |
| 2000 Q2 | 17.52 Million USD | 20.03% |
| 2000 Q1 | 14.59 Million USD | 0.0% |
| 2000 Q4 | 21.79 Million USD | -3.97% |
| 2000 Q3 | 22.69 Million USD | 29.49% |
| 2000 FY | 76.6 Million USD | 18.41% |
| 1999 FY | 64.69 Million USD | 53.27% |
| 1998 FY | 42.2 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -24483.299% |
| BrainsWay Ltd. | 31.78 Million USD | -9226.726% |
| Cerus Corporation | 156.36 Million USD | -1795.86% |
| Envoy Medical, Inc. | 316 Thousand USD | -938032.911% |
| electroCore, Inc. | 16.03 Million USD | -18393.45% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -460226.087% |
| IceCure Medical Ltd | 3.22 Million USD | -91708.609% |
| Inogen, Inc. | 315.66 Million USD | -839.143% |
| OrthoPediatrics Corp. | 148.73 Million USD | -1893.182% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -121996.376% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -812094.006% |
| MaxCyte, Inc. | 41.28 Million USD | -7080.052% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -151735.574% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2676697.775% |
| Orthofix Medical Inc. | 746.64 Million USD | -297.045% |
| PAVmed Inc | 2.45 Million USD | -120801.305% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -13064.439% |
| RxSight, Inc. | 89.07 Million USD | -3228.02% |
| Sight Sciences, Inc. | 81.05 Million USD | -3557.348% |
| SI-BONE, Inc. | 138.88 Million USD | -2034.484% |
| TELA Bio, Inc. | 58.45 Million USD | -4971.596% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -1484.294% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -21380.328% |
| Acutus Medical, Inc. | 7.16 Million USD | -41280.514% |
| Talis Biomedical Corporation | 412 Thousand USD | -719438.835% |
| Spectral AI, Inc. | 18.05 Million USD | -16318.365% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -29829.329% |
| CVRx, Inc. | 39.29 Million USD | -7444.217% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -305926.803% |
| Bioventus Inc. | 512.34 Million USD | -478.614% |
| Venus Concept Inc. | 76.35 Million USD | -3782.573% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -15914.802% |
| LivaNova PLC | 1.15 Billion USD | -156.99% |
| 908 Devices Inc. | 50.22 Million USD | -5801.969% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -514.707% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -3847701.256% |
| NeuroPace, Inc. | 65.42 Million USD | -4431.42% |
| LENSAR, Inc. | 42.16 Million USD | -6930.879% |
| Apyx Medical Corporation | 52.34 Million USD | -5562.954% |
| Cutera, Inc. | 212.36 Million USD | -1295.919% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -8786.924% |
| BioSig Technologies, Inc. | 18 Thousand USD | -16469344.444% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -1678.75% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -12275.287% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | -92.304% |
| Axonics, Inc. | 366.37 Million USD | -709.135% |
| Outset Medical, Inc. | 130.37 Million USD | -2173.808% |
| IRIDEX Corporation | 51.86 Million USD | -5615.36% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -2076.722% |
| IRadimed Corporation | 65.56 Million USD | -4421.654% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -251983.333% |
| INVO Bioscience, Inc. | 3.02 Million USD | -98043.565% |
| Telesis Bio, Inc. | 27.5 Million USD | -10676.473% |
| Viemed Healthcare, Inc. | 183 Million USD | -1519.875% |
| Varex Imaging Corporation | 811 Million USD | -265.536% |
| Quipt Home Medical Corp. | 221.74 Million USD | -1236.914% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -4216.709% |
| Dynatronics Corporation | 32.53 Million USD | -9012.016% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -34061.097% |
| Semler Scientific, Inc. | 68.18 Million USD | -4247.794% |
| InMode Ltd. | 492.04 Million USD | -502.482% |
| Cytosorbents Corporation | 36.34 Million USD | -8055.573% |
| DexCom, Inc. | 3.62 Billion USD | 18.16% |
| Align Technology, Inc. | 3.86 Billion USD | 23.244% |
| Viveve Medical, Inc. | 6.42 Million USD | -46032.898% |
| ZimVie Inc. | 457.43 Million USD | -548.073% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -1435.891% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2676697.775% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -296.473% |
| Profound Medical Corp. | 7.33 Million USD | -40337.751% |
| Insulet Corporation | 1.69 Billion USD | -74.68% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -2251.322% |
| iCAD, Inc. | 17.31 Million USD | -17018.027% |
| Nuwellis, Inc. | 8.86 Million USD | -33344.269% |
| Biotricity, Inc. | 12.06 Million USD | -24474.444% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -501.708% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -47675.987% |
| PAVmed Inc. | 2.45 Million USD | -120801.305% |
| BIOLASE, Inc. | 49.16 Million USD | -5929.819% |
| Beyond Air, Inc. | 1.15 Million USD | -255680.846% |
| FONAR Corporation | 102.88 Million USD | -2781.398% |
| AxoGen, Inc. | 159.01 Million USD | -1764.325% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -980.267% |
| Inari Medical, Inc. | 493.63 Million USD | -500.549% |
| UFP Technologies, Inc. | 400.07 Million USD | -640.992% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -15938072.043% |
| Tenon Medical, Inc. | 2.92 Million USD | -101146.585% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -43418.548% |
| AdaptHealth Corp. | 3.2 Billion USD | 7.364% |
| Sintx Technologies, Inc. | 2.62 Million USD | -112747.354% |
| NanoVibronix, Inc. | 2.28 Million USD | -129751.073% |
| Quanterix Corporation | 122.36 Million USD | -2322.61% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -12047.101% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -1378.399% |
| TransMedics Group, Inc. | 241.62 Million USD | -1126.911% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -21298.152% |
| NeuroMetrix, Inc. | 5.9 Million USD | -50133.63% |
| Hyperfine, Inc. | 11.03 Million USD | -26771.827% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -1695.024% |
| Biomerica, Inc. | 5.41 Million USD | -54646.076% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -5763.214% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -1573.592% |